COVID-19 and Plethora of Fungal Infections

Reetu Kundu1, Nidhi Singla2

  • 1Department of Cytology and Gynecological Pathology, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.

Abstract

Insights

COVID-19 patients face increased risks of fungal co-infections, including invasive candidiasis, aspergillosis, and mucormycosis. Understanding these complications is crucial for reducing patient morbidity and mortality.

Area of Science:

  • * Infectious Diseases
  • * Mycology
  • * Critical Care Medicine

Background:

  • * Severe-acute respiratory coronavirus 2 (SARS-CoV-2) causing COVID-19 has significantly impacted healthcare systems.
  • * COVID-19 presents risk factors for fungal infections such as lung injury, immunosuppression, and treatments like steroids and oxygen therapy.
  • * Emerging fungal co-infections in COVID-19 patients include COVID-19-associated Candida (CAC), COVID-19-associated pulmonary aspergillosis (CAPA), and COVID-19-associated mucormycosis (CAM).

Purpose of the Study:

  • * To review and analyze the spectrum of fungal infections occurring in COVID-19 patients.
  • * To highlight the increased prevalence and severity of fungal pathogens in the context of COVID-19.
  • * To emphasize the need for heightened awareness and understanding of these co-infections.

Main Methods:

  • * This is a review article, synthesizing existing literature on fungal co-infections in COVID-19.
  • * Data was compiled from global reports and scientific literature.
  • * Analysis focused on identifying trends, risk factors, and clinical implications of fungal infections in COVID-19.

Main Results:

  • * COVID-19 creates a conducive environment for fungal infections due to host-related factors and medical interventions.
  • * Significant increases in invasive candidiasis, pulmonary aspergillosis, and mucormycosis outbreaks have been observed in COVID-19 patients.
  • * These co-infections pose a "double trouble" scenario, complicating patient management and increasing healthcare burden.

Conclusions:

  • * Increased awareness and understanding of fungal co-infections in COVID-19 are essential for improving patient outcomes.
  • * Further research is needed to elucidate the pathogenesis of these co-infections.
  • * Development of rapid diagnostic tools, effective antifungal agents, and refined management strategies are critical for the future.

Related Concept Videos

Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
144
Fungal Group Zygomycota01:29

Fungal Group Zygomycota

Zygomycota, previously classified as a distinct fungal group, are primarily terrestrial, saprophytic molds that play a crucial role as decomposers. Recent phylogenetic studies have revealed that these fungi are now divided into two major clades — Mucoromycota, which includes many symbiotic species, and Zoopagomycota, which primarily consists of parasitic and pathogenic fungi. These groups exhibit distinct ecological roles and reproductive strategies while sharing key structural and...
158
Skin Diseases and Disorders01:23

Skin Diseases and Disorders

Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
4.4K
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
340
Overview of Fungi01:29

Overview of Fungi

Fungi are a diverse group of eukaryotes more closely related to animals than other eukaryotes. Fungal cell walls comprise chitin, a polysaccharide that provides structural strength, and glucans, which contribute to flexibility and integrity. Other polysaccharides, such as mannans and galactosans, may supplement or replace chitin in some fungi. These adaptations, along with their preference for acidic environments and tolerance for high osmotic pressure, enable fungi to thrive in various...
224
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
12.4K